ERBB2 and neoplasm: Our study confirms these aspects, with the exception of metastases and staging, which do correlate, since five of the 13 patients in our series who had metastases were HER2-positive and the majority of cases were in advanced stages, possibly due to a greater aggressiveness of the tumor [19].